Multidrug-resistant bacterial infections in the liver transplant setting

Alberto Ferrarese1, Marco Senzolo2, Lolita Sasset3

  • 1Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy. alberto.ferrarese@unipd.it.

Updates in Surgery
|June 25, 2024
PubMed

Insights

Multidrug-resistant organism (MDRO) infections are a severe threat in liver cirrhosis and after liver transplants. Understanding risk factors and prevention is crucial for improving patient outcomes and guiding transplant prioritization.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Bacterial infections are life-threatening in decompensated liver cirrhosis and acute-on-chronic liver failure.
  • Multidrug-resistant organisms (MDROs) are increasingly prevalent in these patients, worsening prognosis.
  • MDRO infections also impact graft and patient survival post-liver transplantation, particularly early post-operatively.

Purpose of the Study:

  • To review MDRO infections in liver disease patients before and after liver transplantation.
  • To discuss epidemiology, risk factors, prevention, and novel therapies for MDRO infections.
  • To examine the role of MDRO infections in liver transplant prioritization for severe cases.

Main Methods:

  • Literature review of MDRO infections in liver disease and transplantation.
  • Analysis of epidemiological data and identified risk factors.
  • Synthesis of current prevention strategies and emerging therapeutic approaches.

Main Results:

  • MDRO infections are a significant complication in liver cirrhosis and post-transplant settings.
  • Risk factors for MDRO infections have been identified, informing preventive measures.
  • Novel therapeutic strategies and their impact on patient survival are under investigation.

Conclusions:

  • MDRO infections pose a substantial challenge in liver disease management and liver transplantation.
  • Effective prevention and treatment strategies are essential to improve patient and graft survival.
  • Consideration of MDRO status is important for prioritizing liver transplantation in critically ill patients.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
356
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177